Azenta (AZTA) Total Non-Current Liabilities (2010 - 2026)
Azenta's (AZTA) quarterly Total Non-Current Liabilities came in at $338.3 million in Q1 2026, up 2.99% year-on-year from $328.5 million in Q1 2025, and down 2.82% on a QoQ basis from $348.1 million in Q4 2025.
Azenta (AZTA) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Azenta (AZTA) has 17 years of Total Non-Current Liabilities data on file, last reported at $338.3 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 2.99% year-over-year to $338.3 million in Q1 2026; TTM through Mar 2026 was $338.3 million, a 2.99% increase from a year earlier, with the FY2025 full-year figure at $348.1 million, changed N/A from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $338.3 million, down from $348.1 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for AZTA reached as high as $686.9 million in Q1 2022 and fell as low as $294.9 million in Q2 2022.
- Historically, Total Non-Current Liabilities has averaged $358.5 million across 5 years, with a median of $338.3 million in 2026.
- Across the five-year window, Total Non-Current Liabilities surged 81.55% in 2022 and plunged 48.58% in 2023, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $402.5 million in 2022, then dropped by 8.49% to $368.3 million in 2023, then dropped by 14.65% to $314.4 million in 2024, then rose by 10.74% to $348.1 million in 2025, then dropped by 2.82% to $338.3 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $338.3 million in Q1 2026, $348.1 million in Q4 2025, and $321.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Azenta | 1.30 Bn | 1.07 Bn | 125.74 Mn | 338.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 338.32 Mn |
| Dec 31, 2025 | 348.13 Mn |
| Sep 30, 2025 | 321.45 Mn |
| Jun 30, 2025 | 345.55 Mn |
| Mar 31, 2025 | 328.50 Mn |
| Dec 31, 2024 | 314.37 Mn |
| Sep 30, 2024 | 323.15 Mn |
| Jun 30, 2024 | 321.31 Mn |
| Mar 31, 2024 | 329.02 Mn |
| Dec 31, 2023 | 368.33 Mn |
| Sep 30, 2023 | 339.05 Mn |
| Jun 30, 2023 | 333.15 Mn |
| Mar 31, 2023 | 353.19 Mn |
| Dec 31, 2022 | 402.53 Mn |
| Sep 30, 2022 | 346.01 Mn |
| Jun 30, 2022 | 294.93 Mn |
| Mar 31, 2022 | 686.91 Mn |
| Dec 31, 2021 | 483.14 Mn |
| Sep 30, 2021 | 488.01 Mn |
| Jun 30, 2021 | 446.99 Mn |